Racial differences in diabetes diagnostic thresholds: study

August 6, 2012

Healthcare providers should take into account differences among racial groups when using hemoglobin A1C levels to diagnose and monitor diabetes, new research from Beth Israel Deaconess Medical Center suggests.

In a study published Aug. 7 in the , researchers analyzed National Health and Nutrition Survey data from 2005 to 2008 to examine the association between hemoglobin A1C levels in black and white adults and the risk for retinopathy, an eye complication of that is detectable early in the disease and can ultimately lead to blindness.

"There have been several studies indicating that hemoglobin A1C levels are consistently higher in blacks than in whites, even though underlying are similar," said lead author Yusuke Tsugawa, MD, MPH, a primary care fellow at Beth Israel Deaconess Medical Center. "We looked at the data to determine if a higher diagnostic cutoff of A1C level should be used to diagnose diabetes in blacks than in whites, or if there should be a single cutoff for all races."

Diabetes has been historically diagnosed based on blood glucose tests, but in 2010 the International Expert Committee recommended adding hemoglobin A1C because it is a more reliable test that reflects average blood sugar over the past two to three months.

In line with the Expert Committee's recommendation, the and the subsequently adopted a hemoglobin A1C level of 6.5 percent or higher as a new diagnostic criterion for diabetes. For people who do not have diabetes, a normal hemoglobin A1C level is around 5 percent.

Given the evidence of naturally higher A1C levels in black people, the researchers expected to also find a delayed development of retinopathy in blacks compared to whites. Instead, the data showed that the A1C level where the risk of retinopathy begins to increase was paradoxically lower in black people compared to white people.

"Our study results show that the risk of diabetic retinopathy is higher for blacks at any given hemoglobin A1C level between 5 percent and 7 percent, and that the higher risk at a hemoglobin A1C level of 5.5 to 5.9 percent for blacks was comparable to the risk at a hemoglobin A1C level of 6.0 to 6.4 percent for whites," said Tsugawa. "This indicates that black people may be more vulnerable to high A1C status than whites."

Further research may bear out the team's hunch that the guidelines may serve those at risk for diabetes better if the diagnostic threshold were lowered for blacks compared to whites.

"Globally, diabetes is one of our most prevalent public health concerns, so this could have important health care delivery and health care policy implications" said Tsugawa. "It may be appropriate for doctors to more closely monitor for early diabetic complications for their black patients than for their white patients and black patients with diabetes may benefit from retinal exams at an earlier stage of their disease."

"And if future studies show that setting race-specific cutoff points for A1C is cost-effective, we might be able to trim healthcare expenditure in diabetes by targeting interventions toward specific, high-risk black populations," said Tsugawa.

The study was not able to examine how long individuals were at the observed A1C status. Since the development of retinopathy depends on both the level of elevated and the duration at that level, further studies with repeated A1C measurements would lend greater validity, and give a fuller picture of the complex associations among A1C level, duration and race.

"Another unanswered question is the underlying mechanism as to why A1C levels are consistently higher in blacks than whites," said senior author Christina Wee, MD, MPH, Associate Section Chief for Research in the Division of General Medicine and Primary Care at BIDMC. "This may be due to biological differences or socio-behavioral differences including disparities in access to health and preventive care, which often lead to dramatically different policy implications. We're unclear on the cause, but we're certain it warrants further investigation."

Explore further: Room for improvement in knowledge of ABC levels, goals

Related Stories

Room for improvement in knowledge of ABC levels, goals

April 19, 2012
(HealthDay) -- Many individuals with diabetes do not know their last hemoglobin A1C (A1C), blood pressure, and low-density lipoprotein (LDL) cholesterol levels (ABC levels), although the correlation between such knowledge ...

2 tests better than 1 to diagnose diabetes in overweight children

May 2, 2011
A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. Researchers from Children's Mercy ...

Many people with type 1 diabetes missing treatment goals: study

June 10, 2012
(HealthDay) -- Many Americans with type 1 diabetes fail to meet their treatment targets, according to researchers who analyzed data from a newly created registry that includes more than 25,000 patients at 67 clinics nationwide.

New NIH fact sheet explains test for diabetes, prediabetes

January 27, 2012
A new fact sheet from the National Institutes of Health explains the A1C test, a widely used and important test to diagnose type 2 diabetes and prediabetes, and to monitor blood glucose levels of people with type 1 and type ...

Hemoglobin A1C inadequate for postpartum diabetes screening

June 19, 2012
(HealthDay) -- For postpartum women who have had gestational diabetes mellitus (GDM), the hemoglobin A1c (A1C) test criteria alone or in combination with fasting glucose test criteria does not provide sensitive and specific ...

Elderly diabetes patients with very low glucose levels have slightly increased risk of death

April 18, 2011
A new study of older diabetes patients has found that well-controlled blood sugar levels were associated with a lower risk of major complications such as heart attacks, amputation and kidney disease, but the very lowest blood ...

Recommended for you

Scientists reverse diabetes in a mouse model using modified blood stem cells

November 15, 2017
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-treated to produce more of a protein called PD-L1, which is deficient in mice (and people) ...

Pregnancy-related conditions taken together leave moms—and dads—at risk

November 14, 2017
Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team ...

Study reveals how a very low calorie diet can reverse type 2 diabetes

November 9, 2017
In a new study, a Yale-led research team uncovers how a very low calorie diet can rapidly reverse type 2 diabetes in animal models. If confirmed in people, the insight provides potential new drug targets for treating this ...

Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs

November 7, 2017
Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes.

Researchers link Western diet to vascular damage and prediabetes

October 31, 2017
Could short-term exposure to the average American diet increase one's risk for developing diabetes and cardiovascular disease? According to a recent study funded by the American Heart Association (AHA), researchers from New ...

Researchers design synthetic beta cells to secrete insulin in response to high blood sugar

October 30, 2017
Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. But researchers from the University of North Carolina ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.